NO20032315L - 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer - Google Patents

4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer

Info

Publication number
NO20032315L
NO20032315L NO20032315A NO20032315A NO20032315L NO 20032315 L NO20032315 L NO 20032315L NO 20032315 A NO20032315 A NO 20032315A NO 20032315 A NO20032315 A NO 20032315A NO 20032315 L NO20032315 L NO 20032315L
Authority
NO
Norway
Prior art keywords
biphenylcarbonylamino
piperidine derivatives
mtp inhibitors
mtp
inhibitors
Prior art date
Application number
NO20032315A
Other languages
English (en)
Other versions
NO20032315D0 (no
Inventor
Alyx-Caroline Guevel
Didier Festal
Francois Collonges
Daniel Guerrier
Olivier Chevreuil
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20032315D0 publication Critical patent/NO20032315D0/no
Publication of NO20032315L publication Critical patent/NO20032315L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20032315A 2000-11-23 2003-05-22 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer NO20032315L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0015143A FR2816940A1 (fr) 2000-11-23 2000-11-23 Derives de 4-(biphenylcarbonylamino)-piperidine, compositions les contenant et leur utilisation
PCT/EP2001/012326 WO2002042291A1 (en) 2000-11-23 2001-10-25 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors

Publications (2)

Publication Number Publication Date
NO20032315D0 NO20032315D0 (no) 2003-05-22
NO20032315L true NO20032315L (no) 2003-05-22

Family

ID=8856805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032315A NO20032315L (no) 2000-11-23 2003-05-22 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer

Country Status (20)

Country Link
US (1) US20040034028A1 (no)
EP (1) EP1335912A1 (no)
JP (1) JP2004514676A (no)
KR (1) KR20030060954A (no)
CN (1) CN1476445A (no)
AR (1) AR031499A1 (no)
AU (1) AU2002221745A1 (no)
BR (1) BR0115520A (no)
CA (1) CA2429326A1 (no)
CZ (1) CZ20031619A3 (no)
FR (1) FR2816940A1 (no)
HU (1) HUP0400819A2 (no)
IL (1) IL155986A0 (no)
MX (1) MXPA03004540A (no)
NO (1) NO20032315L (no)
PE (1) PE20020595A1 (no)
PL (1) PL365939A1 (no)
RU (1) RU2003117458A (no)
SK (1) SK7362003A3 (no)
WO (1) WO2002042291A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210616A (pt) 2001-06-28 2004-09-28 Pfizer Prod Inc Indóis, benzofuranos e benzotiofenos substituìdos com triamida, composição farmacêutica, uso dos referidos compostos, bem como processo para preparação dos mesmos
ZA200502496B (en) 2002-02-28 2005-10-12 Japan Tobacco Inc Ester compound and medicinal use thereof.
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP4832897B2 (ja) 2003-08-29 2011-12-07 日本たばこ産業株式会社 エステル誘導体及びその医薬用途
FR2865733B1 (fr) 2004-02-04 2007-10-12 Merck Sante Sas Derives de thiazolylimidazole, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en medecine
FR2871463B1 (fr) * 2004-06-11 2006-09-22 Merck Sante Soc Par Actions Si Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
US8101774B2 (en) 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
FR2884831B1 (fr) * 2005-04-22 2007-08-10 Merck Sante Soc Par Actions Si Methode de criblage de composes inhibiteurs de la mtp
KR101387459B1 (ko) 2006-10-24 2014-05-14 얀센 파마슈티카 엔.브이. Ｍｔｐ를 저해하는 테트라하이드로-나프탈렌-1-카복실산 유도체
JO2653B1 (en) * 2006-10-24 2012-06-17 شركة جانسين فارماسوتيكا ان. في Tetrahydroflavin 1-carboxylic acid substituted with pyridine or pyrazine inhibit MTB
US8338455B2 (en) * 2006-12-20 2012-12-25 Amgen Inc. Compounds and methods of use
AR074466A1 (es) 2008-12-05 2011-01-19 Sanofi Aventis Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
EP2473504B1 (en) 2009-09-03 2015-02-25 Bioenergenix Heterocyclic compounds for the inhibition of pask
BR112013017164B1 (pt) 2011-01-05 2021-05-04 Bioenergenix composto e composição farmacêutica
US8916561B2 (en) 2011-03-02 2014-12-23 Bioenergenix, Llc Substituted quinoxaline compounds for the inhibition of PASK
EP2681207B1 (en) 2011-03-02 2016-12-28 Bioenergenix Heterocyclic compounds for the inhibition of pask
JP6664632B2 (ja) * 2013-09-30 2020-03-13 国立大学法人 東京大学 アディポネクチン受容体活性化化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528234D0 (en) * 1985-11-15 1985-12-18 Wyeth John & Brother Ltd Heterocyclic compounds
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
CA2123728A1 (en) * 1993-05-21 1994-11-22 Noriyoshi Sueda Urea derivatives and their use as acat inhibitors
US6130232A (en) * 1995-10-13 2000-10-10 Banyu Pharmaceutical Coaltd Substituted piperidine derivatives as muscarinic M3 receptor antagonists
WO1997045414A1 (fr) * 1996-05-31 1997-12-04 Banyu Pharmaceutical Co., Ltd. Derives de piperidine a disubstitution en positions 1,4

Also Published As

Publication number Publication date
MXPA03004540A (es) 2003-09-10
NO20032315D0 (no) 2003-05-22
CN1476445A (zh) 2004-02-18
CZ20031619A3 (cs) 2003-09-17
RU2003117458A (ru) 2004-12-27
AU2002221745A1 (en) 2002-06-03
HUP0400819A2 (hu) 2004-07-28
AR031499A1 (es) 2003-09-24
JP2004514676A (ja) 2004-05-20
PL365939A1 (en) 2005-01-24
US20040034028A1 (en) 2004-02-19
IL155986A0 (en) 2003-12-23
SK7362003A3 (en) 2003-11-04
WO2002042291A1 (en) 2002-05-30
FR2816940A1 (fr) 2002-05-24
CA2429326A1 (en) 2002-05-30
EP1335912A1 (en) 2003-08-20
BR0115520A (pt) 2003-09-16
KR20030060954A (ko) 2003-07-16
PE20020595A1 (es) 2002-07-08

Similar Documents

Publication Publication Date Title
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
NO20030055D0 (no) Colchinolderivater som angiogenese inhibitorer
NO20030135L (no) Piperidinforbindelser for anvendelse som CCR-3-inhibitorer
NO20026125D0 (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
DE60211317D1 (de) Rho-kinase inhibitoren
DE60218138D1 (de) Rho-kinase inhibitoren
DK1326858T3 (da) Piperidinforbindelser som anti-allergiske midler
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
ATE441631T1 (de) Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
ATE524441T1 (de) Vla-4-inhibitoren
DK1460066T3 (da) Piperazinforbindelse som tachykinin-inhibitorer
NO20014642L (no) Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
ATE370137T1 (de) 4-(6-gliedriger)-heteroaryl-acyl-pyrrolidin derivate als hcv-inhibitoren
DE60320933D1 (de) Rho-kinase inhibitoren
DK1650203T3 (da) Quinolinonderivater som tyrosinkinaseinhibitorer
NO20034308D0 (no) Nye tyrokinase-inhibitorer
NO20032315D0 (no) 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
DK1360184T3 (da) Piperidinderivater som neurokinin-1-antagonister
NO20035440D0 (no) Pyrrolidinderivater som faktor-XA-inhibitorer
NO20032807L (no) Substituerte 8-arylkinolin-fosfodiesterase-4-inhibitorer
NO20021959L (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application